应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BK4139 生物科技
交易中 11-16 14:14:51 EST
1,399.46
-15.22
-1.08%
最高
1,430.96
最低
1,399.33
成交量
4.45亿
今开
1,414.68
昨收
1,414.67
日振幅
2.24%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
87.03亿
换手率
--
流通股本
0.00
市净率
8.127336
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
亚盛医药(06855)旗下两款原创1类新药成功纳入新版国家医保药品目录
金吾财讯 · 11-16 09:11
亚盛医药(06855)旗下两款原创1类新药成功纳入新版国家医保药品目录
FFR机器人完成密歇根州大学实验室首单交付;轮臂机器人Faber U完成分拣场景仿真验证;正推进汉福德工厂机器人制造计划及资本合作
FaradayFuture · 11-16 08:46
FFR机器人完成密歇根州大学实验室首单交付;轮臂机器人Faber U完成分拣场景仿真验证;正推进汉福德工厂机器人制造计划及资本合作
亚盛医药:亚盛医药利生妥成功纳入2026年国家医保药品目录 耐立克续约
智通财经 · 11-16 07:30
亚盛医药:亚盛医药利生妥成功纳入2026年国家医保药品目录 耐立克续约
美亚杯”Alpha Go时刻——智能体取证首超“取证大师
同花顺 · 11-15 23:21
美亚杯”Alpha Go时刻——智能体取证首超“取证大师
婚纱租赁押金退款延迟 VERA WANG致歉
新浪科技 · 11-15 11:54
婚纱租赁押金退款延迟 VERA WANG致歉
亚盛医药利生妥®成功纳入2026年国家医保药品目录,耐立克®续约
美通社 · 11-14 18:12
亚盛医药利生妥®成功纳入2026年国家医保药品目录,耐立克®续约
中国首个国产原创Bcl-2抑制剂利沙托克拉纳入新版国家医保目录,亚盛医药(06855)双引擎布局与全球开发同步推进
智通财经 · 11-14 14:25
中国首个国产原创Bcl-2抑制剂利沙托克拉纳入新版国家医保目录,亚盛医药(06855)双引擎布局与全球开发同步推进
EBS 分散剂商品报价动态(2026-11-14)
市场资讯 · 11-14 14:01
EBS 分散剂商品报价动态(2026-11-14)
再鼎医药宣布呫诺美林曲司氯铵胶囊(I)/(II)/(III)与艾加莫德α注射液(皮下注射)首次纳入2026年国家医保药品目录
格隆汇 · 11-14 11:32
再鼎医药宣布呫诺美林曲司氯铵胶囊(I)/(II)/(III)与艾加莫德α注射液(皮下注射)首次纳入2026年国家医保药品目录
加拿大阿尔伯塔省财政部长表示,随着特许权使用费制度调整,预计该省将立即迎来新的油砂投资。
格隆汇 · 11-14 04:52
加拿大阿尔伯塔省财政部长表示,随着特许权使用费制度调整,预计该省将立即迎来新的油砂投资。
再鼎医药(ZLAB)新型双特异性抗体ZL-1503公布积极I/Ib期人体数据
金吾财讯 · 11-13
再鼎医药(ZLAB)新型双特异性抗体ZL-1503公布积极I/Ib期人体数据
戴德梁行:中国奥特莱斯行业逆势增长态势明确
新华财经 · 11-13
戴德梁行:中国奥特莱斯行业逆势增长态势明确
高和资本周以升:多层次REITs为城市更新提供退出通道,应推动不动产资产管理行业发展
长三角资本局 · 11-13
高和资本周以升:多层次REITs为城市更新提供退出通道,应推动不动产资产管理行业发展
Bithumb 将上线 NeoSoul(DNA),DNA 短时突破 0.27 美元
链捕手 · 11-13
Bithumb 将上线 NeoSoul(DNA),DNA 短时突破 0.27 美元
FFR第三季机器人收入230万美元,毛利率26%
雷递网 · 11-13
FFR第三季机器人收入230万美元,毛利率26%
FFR公布Q3业绩 合并的机器人业务累计收入约230万美元,将启动机器人教育“百城计划”,CES期间将发布Physical Cloud技术平台及生产力Token
FaradayFuture · 11-13
FFR公布Q3业绩 合并的机器人业务累计收入约230万美元,将启动机器人教育“百城计划”,CES期间将发布Physical Cloud技术平台及生产力Token
数据:某巨鲸以 4 倍和 6 倍杠杆做空 ANT 和 ANTH,浮盈 69.6 万美元
链捕手 · 11-12
数据:某巨鲸以 4 倍和 6 倍杠杆做空 ANT 和 ANTH,浮盈 69.6 万美元
多只公募REITs发布二级市场波动风险提示
格隆汇 · 11-12
多只公募REITs发布二级市场波动风险提示
CDMO龙头凯莱英抛出最高7亿元回购方案:上限246元/股,不超六成用于激励、不低于四成用于注销
每日经济新闻 · 11-12
CDMO龙头凯莱英抛出最高7亿元回购方案:上限246元/股,不超六成用于激励、不低于四成用于注销
再鼎医药(09688)根据股份计划发行合计710万股
智通财经 · 11-12
再鼎医药(09688)根据股份计划发行合计710万股
加载更多
公司概况
公司名称:
生物科技
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"生物科技","latestPrice":1399.4553,"timestamp":1794856490960,"preClose":1414.6743,"halted":0,"volume":444646713,"delay":0,"changeRate":-0.010758,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-15.218994,"latestTime":"11-16 14:14:51 EST","open":1414.678,"high":1430.9576,"low":1399.3269,"amount":8702838404.624928,"amplitude":0.022359,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1794862800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.127336,"peRate":-225.893141,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4139","defaultTab":"news","newsList":[{"id":"2683666301","title":"亚盛医药(06855)旗下两款原创1类新药成功纳入新版国家医保药品目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683666301","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683666301?lang=zh_cn&edition=full","pubTime":"2026-11-16 09:11","pubTimestamp":1794791476,"startTime":"0","endTime":"0","summary":"耐立克通过重新谈判成功续约国家医保药品目录,用于1、对一代和二代酪氨酸激酶抑制剂耐药和/或不耐受的慢性髓细胞白血病慢性期(-CP)成年患者;及2、T315I突变的CML-CP或加速期(-AP)的成年患者。截至目前,亚盛医药两款创新药的全部获批适应症均已纳入国家医保药品目录,将为更多患者提供更加可及的创新治疗选择。新版国家医保药品目录将于2027年1月1日起正式实施。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/ZmY0OWUwYjc0ZDYzZDFkYzRkNWJlMTY3NjE5MjUxNjU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZmY0OWUwYjc0ZDYzZDFkYzRkNWJlMTY3NjE5MjUxNjU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1996063","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK1574","BK1161","06855","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683666444","title":"FFR机器人完成密歇根州大学实验室首单交付;轮臂机器人Faber U完成分拣场景仿真验证;正推进汉福德工厂机器人制造计划及资本合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2683666444","media":"FaradayFuture","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683666444?lang=zh_cn&edition=full","pubTime":"2026-11-16 08:46","pubTimestamp":1794789960,"startTime":"0","endTime":"0","summary":"先分享机器人部署“百城计划”的又一进展。FFR已经向密歇根州首个客户Central Michigan University交付两台Aegis Ultra,完成了在密歇根州的大学实验室首单销售与交付。工业与物流生态方面,团队近期通过轮臂机器人Faber U完成了根据标签分拣工件的场景仿真验证,为后续实机测试及真实场景POC奠定基础。本周,FFR发布了完成机器人业务收购后的首次财报。FFAI方面,战略与业务升级也在持续推进,包括推进FFR机器人在汉福德工厂的本体制造、测试与验证中心建设。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI0Njg2MzI3Mw==&mid=2247490035&idx=1&sn=445a6501fa833b5b554883ee704b6bff&chksm=e88947d6267e1f2bfae33f17fc7a9973b6a309426c9d37d481826928833fd44d5b38395c6054&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["ROBO","TSNF","BK4139","KOMP","FFR","PBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683663832","title":"亚盛医药:亚盛医药利生妥成功纳入2026年国家医保药品目录 耐立克续约","url":"https://stock-news.laohu8.com/highlight/detail?id=2683663832","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683663832?lang=zh_cn&edition=full","pubTime":"2026-11-16 07:30","pubTimestamp":1794785458,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683081654","title":"美亚杯”Alpha Go时刻——智能体取证首超“取证大师","url":"https://stock-news.laohu8.com/highlight/detail?id=2683081654","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683081654?lang=zh_cn&edition=full","pubTime":"2026-11-15 23:21","pubTimestamp":1794756060,"startTime":"0","endTime":"0","summary":"11月15日,“美亚杯”第十二届中国电子数据取证大赛在厦门闭幕。大赛首日,赛场出现了往届从未有过的一幕:答题位空着,屏幕上跑的不是取证软件,而是选手刚搭好的取证智能体——它读检材、 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261115/c681831839.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261115/c681831839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["ALP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683658839","title":"婚纱租赁押金退款延迟 VERA WANG致歉","url":"https://stock-news.laohu8.com/highlight/detail?id=2683658839","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683658839?lang=zh_cn&edition=full","pubTime":"2026-11-15 11:54","pubTimestamp":1794714840,"startTime":"0","endTime":"0","summary":"11月15日上午消息,关于近期婚纱租赁押金退款延迟的相关报道,VERA WANG婚纱官方账号发布致歉声明。我们对此高度重视,已直接对接受影响顾客,目前所有超出商定退款时限的押金均已退还;其余相关未到商定退款时限的押金,将与顾客协商按计划完成退款。近日,有多位网友在社交平台上反馈婚纱品牌Vera Wang拖欠数万元押金。按约定押金应在7至15个工作日内退还,部分顾客却被拖延长达近2个月。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/shenji/2026-11-15/doc-iniyuuaf2075532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4585","VERA","LU2324357040.USD","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683636613","title":"亚盛医药利生妥®成功纳入2026年国家医保药品目录,耐立克®续约","url":"https://stock-news.laohu8.com/highlight/detail?id=2683636613","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683636613?lang=zh_cn&edition=full","pubTime":"2026-11-14 18:12","pubTimestamp":1794651120,"startTime":"0","endTime":"0","summary":"截至目前,亚盛医药两款高质量全球创新药的全部获批适应症均已纳入国家医保药品目录,将为更多患者提供更加可及的创新治疗选择。利生妥于2025年7月在中国获批上市,是中国首个上市的国产原创Bcl-2抑制剂。此次利生妥成功纳入新版国家医保药品目录,将大大提升国内CLL/SLL患者的用药可及性,让更多患者能够及时获得新的治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"https://www.prnasia.com/story/archive/5097943_ZH97943_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnasia.com/story/archive/5097943_ZH97943_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["AAPG","BK1574","BK1161","06855","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683368038","title":"中国首个国产原创Bcl-2抑制剂利沙托克拉纳入新版国家医保目录,亚盛医药(06855)双引擎布局与全球开发同步推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2683368038","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683368038?lang=zh_cn&edition=full","pubTime":"2026-11-14 14:25","pubTimestamp":1794637518,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,亚盛医药今日宣布,公司两款原创1类新药成功纳入2026年国家医保药品目录。截至目前,两款产品的全部获批适应症均已纳入国家医保药品目录。利生妥是中国首个上市的国产原创Bcl-2抑制剂,也是全球第二个上市的Bcl-2抑制剂、全球首个单药治疗布鲁顿酪氨酸激酶抑制剂经治慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的Bcl-2抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523262.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国首个国产原创Bcl-2抑制剂利沙托克拉纳入新版国家医保目录,亚盛医药(06855)双引擎布局与全球开发同步推进","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","AAPG","BK1161","06855","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683800336","title":"EBS 分散剂商品报价动态(2026-11-14)","url":"https://stock-news.laohu8.com/highlight/detail?id=2683800336","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683800336?lang=zh_cn&edition=full","pubTime":"2026-11-14 14:01","pubTimestamp":1794636060,"startTime":"0","endTime":"0","summary":"生意社11月14日讯交易商品牌/产地交货地最新报价EBS分散剂 工业级山东隆汇化工有限公司隆汇化工山东省38000元/吨新浪合作大平台期货开户 安全快捷有保障","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/future/nyzx/2026-11-14/doc-iniysrax0318193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683682607","title":"再鼎医药宣布呫诺美林曲司氯铵胶囊(I)/(II)/(III)与艾加莫德α注射液(皮下注射)首次纳入2026年国家医保药品目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683682607","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683682607?lang=zh_cn&edition=full","pubTime":"2026-11-14 11:32","pubTimestamp":1794627171,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","ZLAB","BK4531","BK4588","III","BK4548","LU2488822045.USD","BK4134","BK4585","BK1161","BK1574","09688","BK1588","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683710688","title":"加拿大阿尔伯塔省财政部长表示,随着特许权使用费制度调整,预计该省将立即迎来新的油砂投资。","url":"https://stock-news.laohu8.com/highlight/detail?id=2683710688","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683710688?lang=zh_cn&edition=full","pubTime":"2026-11-14 04:52","pubTimestamp":1794603149,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","PTNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683650812","title":"再鼎医药(ZLAB)新型双特异性抗体ZL-1503公布积极I/Ib期人体数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2683650812","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683650812?lang=zh_cn&edition=full","pubTime":"2026-11-13 20:32","pubTimestamp":1794573162,"startTime":"0","endTime":"0","summary":"金吾财讯 | 再鼎医药 宣布,其自主研发的新型长效IL-13/IL-31Rα双特异性抗体ZL-1503在全球I/Ib期临床试验的单次递增剂量部分中,取得了积极的首次人体试验初步数据。安全性上,ZL-1503在所有评估剂量下均耐受良好,未报告严重不良事件或抗药抗体。再鼎医药透露,旨在评估该药在中重度特应性皮炎患者中多次递增剂量的B部分试验队列数据预计将于2027年上半年公布。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/ODU0MDcxNDc2MTQ4MzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ODU0MDcxNDc2MTQ4MzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"308342","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4139","BK1574","BK4585","BK4588","ZLAB","BK4548","BK4526","BK4531","09688","BK1588","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683508359","title":"戴德梁行:中国奥特莱斯行业逆势增长态势明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2683508359","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683508359?lang=zh_cn&edition=full","pubTime":"2026-11-13 20:27","pubTimestamp":1794572823,"startTime":"0","endTime":"0","summary":"新华财经北京11月13日电12日,房地产服务及咨询机构戴德梁行发布2026年度《中国奥特莱斯行业分析与价值洞察》报告,围绕市场现状、运营商格局、海外市场经验、REITs资本化发展与资产估值逻辑五大维度展开系统剖析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://bond.eastmoney.com/a/202611133930883341.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://bond.eastmoney.com/a/202611133930883341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["URE","RJMG","TRUR","BPRE","BK4007","REIT","CFA","DFRA","RIET","YLDW","IVRA","BK4139","MDIV","PSCF","RNTY","XHOA","GRI","IQRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683657851","title":"高和资本周以升:多层次REITs为城市更新提供退出通道,应推动不动产资产管理行业发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2683657851","media":"长三角资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683657851?lang=zh_cn&edition=full","pubTime":"2026-11-13 16:09","pubTimestamp":1794557340,"startTime":"0","endTime":"0","summary":"在“REITs市场发展展望”圆桌讨论中,高和资本执行合伙人周以升表示,多层次REITs市场的建设,为存量资产盘活、城市更新及不动产基金投资提供了重要支持,尤其是逐步完善的退出机制,有助于增强社会资本参与城市更新的信心。对于未来市场建设,周以升提出,机构间REITs应坚持权益化、平台化、并购化,并将资产管理能力作为核心。他强调,不能仅将REITs视为金融产品或退出通道,更应重视其背后的持续运营和资产管理体系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/csjzbj/2026-11-13/doc-iniyqsmz1205094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","JJJ.SI","XHOA","BCFN","GLS.SI","CLR.SI","BK4129","BK4123","SRT.SI","SRU.SI","CFA","URE","BK4007","ARCAY","TRUR","RIET","CFA.SI","BPRE","GRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683529951","title":"Bithumb 将上线 NeoSoul(DNA),DNA 短时突破 0.27 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2683529951","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683529951?lang=zh_cn&edition=full","pubTime":"2026-11-13 13:26","pubTimestamp":1794547601,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,据官方公告,Bithumb 将在韩元市场上线 NeoSoul 的 DNA 交易对。充值和提现已开放,交易计划于 16:00(韩国时间)开始。DNA 短时突破 0.27 美元(约 360 韩元)。\n\n据 Dune 数据,NeoSoul 旗下 AI 交易产品 NeoTrade 累计下载量超过 73 万,累计订阅量超过 3.8 万,累计订阅收入超过 52 万美元。DNA 目前已可在 NeoTrade 和 NeoLand 中使用。\n ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2304424","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDN","UUP","DNA","BK4121","BK4139","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683540838","title":"FFR第三季机器人收入230万美元,毛利率26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2683540838","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683540838?lang=zh_cn&edition=full","pubTime":"2026-11-13 10:59","pubTimestamp":1794538790,"startTime":"0","endTime":"0","summary":"FF EAI Robotics(简称FFR)今日公布2026年第三季度财务业绩,并介绍了机器人业务近期进展及未来规划。截至2026年9月30日,合并的机器人业务累计收入约230万美元,毛利约为59.3万美元,毛利率约为26%;公司还将启动机器人教育“百城计划”,并在CES期间将发布Physical Cloud技术平台及生产力Token。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261113/6393016438798905792757701.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261113/6393016438798905792757701.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35716/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["ROBO","BK4139","FFR","KOMP","PBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683546208","title":"FFR公布Q3业绩 合并的机器人业务累计收入约230万美元,将启动机器人教育“百城计划”,CES期间将发布Physical Cloud技术平台及生产力Token","url":"https://stock-news.laohu8.com/highlight/detail?id=2683546208","media":"FaradayFuture","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683546208?lang=zh_cn&edition=full","pubTime":"2026-11-13 07:00","pubTimestamp":1794524400,"startTime":"0","endTime":"0","summary":"·公司计划在CES期间发布Physical Cloud技术平台和生产力Token,结合机器人大脑及开发者平台能力,致力于降低教育机构和K-12学校使用多形态机器人的门槛。2026年三季度及近期业务亮点10月23日,FFR完成对FFAI机器人业务的收购。作为交易对价,FFR将按计划发行普通股及无投票权可转换优先股。交易完成后,FFR作为“四核全智”人形和仿生Physical AI机器人生态Pure-Play第一股正式上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI0Njg2MzI3Mw==&mid=2247490033&idx=1&sn=774148a750cd5b4e4863bca250a35bc7&chksm=e8a49f189eea0d5e3de378b965ac26ddcc807c765383797f7132dda5beda8fe8ede9e9c55937&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["FFR","ROBO","KOMP","BK4139","PBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682759239","title":"数据:某巨鲸以 4 倍和 6 倍杠杆做空 ANT 和 ANTH,浮盈 69.6 万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682759239","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682759239?lang=zh_cn&edition=full","pubTime":"2026-11-12 21:48","pubTimestamp":1794491313,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,据链上分析师 @ai_9684xtpa 监测,归属于同一巨鲸的两个地址分别以 4 倍和 6 倍杠杆做空 ANT 和 ANTH,当前累计空单价值 7233 万美元,浮盈 69.6 万美元。\n\nANT 追踪 Anthropic 股价,ANTH 追踪其整体估值。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2304221","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SDOW","SDP","TTXD","DIA","DOG","CLDS","BK4139","DDM","ANTH","DXD","UDOW","SDD","ANT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682560049","title":"多只公募REITs发布二级市场波动风险提示","url":"https://stock-news.laohu8.com/highlight/detail?id=2682560049","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682560049?lang=zh_cn&edition=full","pubTime":"2026-11-12 19:56","pubTimestamp":1794484606,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","GRI","FATT","BK4007","BPRE","CFA","XHOA","TRUR","URE","RIET"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682598873","title":"CDMO龙头凯莱英抛出最高7亿元回购方案:上限246元/股,不超六成用于激励、不低于四成用于注销","url":"https://stock-news.laohu8.com/highlight/detail?id=2682598873","media":"每日经济新闻","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682598873?lang=zh_cn&edition=full","pubTime":"2026-11-12 19:50","pubTimestamp":1794484211,"startTime":"0","endTime":"0","summary":"CDMO(合同研发生产组织)龙头凯莱英(SZ002821,股价152.68元,市值552.62亿元)A股回购方案进入了实操披露阶段。公司11月12日晚间发布的回购股份报告书显示,本次回购资金总额不低于5亿元(含)且不超过7亿元(含),回购价格不超过246元/股(含),实施期限为董事会审议通过回购方案之日起12个月内。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611123929793757.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611123929793757.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","LU1328615791.USD","06821","BK4139","BK1191","CDMO","BK0132","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682456929","title":"再鼎医药(09688)根据股份计划发行合计710万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2682456929","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682456929?lang=zh_cn&edition=full","pubTime":"2026-11-12 17:59","pubTimestamp":1794477587,"startTime":"0","endTime":"0","summary":"智通财经APP讯,再鼎医药(09688)发布公告,于2026年11月12日,就根据股份计划授予参与人(发行人的董事除外)的股份奖励或期权而发行合计710万股新股或转让库存股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1522366.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4526","BK4585","BK4139","BK1574","BK4531","ZLAB","09688","BK4548","BK4588","BK1161","LU2488822045.USD","BK1588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"生物科技","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK4139,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}